SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending intensely as news circulates regarding a criminal investigation into the Federal Reserve Chair, sparking widespread debate on the independence of monetary policy. Community sentiment is polarized, with some anticipating significant market volatility while others view it as a politically motivated event poised for a rapid rebound. Investors are closely monitoring the situation for broader implications on market stability and the direction of future rates.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The tech-heavy QQQ is trending amid swirling uncertainty from a reported federal probe into Fed Chair Powell, sparking community debate over market resilience versus potential downside. Investors are also digesting President Trump's recent actions, including a proposed credit card interest rate cap and escalating geopolitical tensions, adding complexity to the current all-time high market environment.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is capturing significant market attention, primarily driven by reports of a criminal investigation into the Fed Chair and heightened global geopolitical tensions. The community is debating whether gold's ascent signals a crucial safe-haven move amidst currency debasement and instability, or if it represents a manipulated bull trap ahead of commodity index rebalancing. This dynamic interplay of systemic risk and central bank actions is generating strong interest in the metal's immediate trajectory.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is experiencing a surge in interest amid high-level discussions concerning Greenland's critical mineral resources, particularly its massive Tanbreez rare earth project. The community is actively discussing potential strategic deals and government investments aimed at securing a vital non-Chinese supply chain, fueling strong bullish sentiment and anticipation of significant revaluation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing heightened investor attention following recent positive FDA feedback that significantly de-risked its lead asset, Sonelokimab, for a key inflammatory skin disease, validating its 'best-in-class' potential. This regulatory clarity has intensified community discussions around accelerated timelines and fueled widespread speculation about an imminent buyout, with many anticipating a significant competitive offer from major pharmaceutical players.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

Geopolitical events, including military actions in Venezuela and upcoming Supreme Court decisions on tariffs, are sparking intense community debate around potential market volatility. Many traders are speculating if these catalysts will finally trigger a significant 'spike' in this 2x long VIX futures ETF, while others caution against its inherent decay and contango, branding it a 'broken instrument' unsuitable for long-term holds amidst prevailing broader market strength.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending significantly higher, defying expectations of a rebalancing selloff from commodity indices, as the community cites persistent physical shortages and silver's critical mineral designation. Discussions are rife with anticipation of a massive short squeeze and new all-time highs, while some voices warn of an overextended market and imminent retracement. This intense debate underscores silver's dual role as a precious metal and essential industrial component.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is drawing significant attention after a substantial stock and warrant offering to an institutional investor at a premium, which the community interprets as a strong endorsement for its strategic expansion. This capital injection is sparking broad discussion about potential acquisitions and the company's accelerating role in the global drone and counter-drone defense and security markets. Investors widely view this as positioning Ondas as a leader in a rapidly evolving technological landscape.

Monero

Monero (XMR) is trending higher as the crypto community re-emphasizes the critical importance of privacy in digital assets, with many viewing it as a robust, truly anonymous digital currency. Community discussions highlight its unique fungibility and resilience, especially as investors consider alternatives to less private cryptocurrencies and note XMR's steady performance amidst broader market fluctuations. The ongoing conversation centers on its core utility for financial privacy and its distinct position in the crypto ecosystem.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

PSLV is trending amidst intense community discussion around a looming "silver squeeze," fueled by reports of a severe physical supply deficit and soaring industrial demand from sectors like EVs, solar, and AI. Investors are actively favoring PSLV for its direct physical backing, believing that years of market manipulation are ending and ushering in a significant price discovery phase for silver, despite some temporary market rebalancing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) have been given an average rating of "Moderate Buy" by the nine analysts that are covering the firm, Marketbeat.com reports...

Notable Friday Option Activity: DAWN, XPO, UUUU

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Day One Biopharmaceuticals Inc (Symbol: DAWN), where a total volume of 13,188...

Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 5.5% - Still a Buy?

Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Up 5.5% - Time to Buy...

Day One Biopharmaceuticals Target of Unusually Large Options Trading (NASDAQ:DAWN)

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders purchased 5,027 call options on the stock. This represents...

Braidwell LP Has $14.18 Million Position in Day One Biopharmaceuticals, Inc. $DAWN

Braidwell LP reduced its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 38.3% during the second quarter, according to the company in its most recent 13F filing...

Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 4.9% - What's Next?

Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Down 4.9% - Should You Sell...

Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase - Time to Buy?

Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase - Time to Buy...

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Moderate Buy" from Analysts

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat Ratings...

180,133 Shares in Day One Biopharmaceuticals, Inc. $DAWN Bought by Schroder Investment Management Group

Schroder Investment Management Group acquired a new stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) during the second quarter, according to its most recent Form 13F...

Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC boosted its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 11.2% during the second quarter, according to the company in its most recent...

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

DAWN
Day One Biopharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DAWN News

DAWNDay One Biopharmaceuticals Inc